Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses
General and administrative	$ 1,360,138	$ 1,885,753
Research and development	746,371	506,155
Depreciation and amortization	81,024	85,409
Total operating expenses	2,187,533	2,477,317
Loss from operations	(2,187,533)	(2,477,317)
Other income
Other income	2,565	21,437
Interest income, net	2	696
Total other income	2,567	22,133
Net loss before income taxes	(2,184,966)	(2,455,184)
Income tax expense		(1,731)
Net loss	(2,184,966)	(2,456,915)
Other comprehensive loss
Foreign currency translation	(3,487)	17,906
Comprehensive loss	$ (2,188,453)	$ (2,439,009)
Net loss per share - basic	$ (1.22)	$ (9.21)
Net loss per share - diluted	$ (1.22)	$ (9.21)
Weighted average shares outstanding, basic	1,797,774	266,764
Weighted average shares outstanding, diluted	1,797,774	266,764